Vitality Watch

Dossier clinicaltrials observational 14-sep-2026
Human cohort, case-control, or epidemiological association

Preoperative Sarcopenia and Postoperative Outcomes in Older Patients With Gastrointestinal Cancer

Key claim: A prospective cohort will test whether preoperative sarcopenia (EWGSOP2, SARC-F, and calf circumference) predicts 90-day complications, length of stay, and mortality after elective GI cancer surgery in adults ≥60.

Abstract

This prospective cohort study aims to evaluate the association between preoperative sarcopenia and postoperative outcomes in patients aged 60 years or older undergoing elective surgery for gastrointestinal cancer. Sarcopenia will be assessed preoperatively using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria, including muscle strength, muscle mass, and physical performance, together with the Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire and calf circumference measurement. Participants will be followed for 90 days after surgery. Postoperative complications, length of hospital stay, and 30-day and 90-day mortality will be evaluated.

Why this matters

A prospective cohort will test whether preoperative sarcopenia (EWGSOP2, SARC-F, and calf circumference) predicts 90-day complications, length of stay, and mortality after elective GI cancer surgery in adults ≥60.

Source

Link

Briefing card

Preoperative Sarcopenia and Postoperative Outcomes in Older Patients With Gastrointestinal Cancer
Stage: observational · clinicaltrials · 14-sep-2026

A prospective cohort will test whether preoperative sarcopenia (EWGSOP2, SARC-F, and calf circumference) predicts 90-day complications, length of stay, and mortality after elective GI cancer surgery in adults ≥60.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07817758

build build 880 · 2bcef25 · 2026-11-18